Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | ||
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 4,390.11 | 3,443.22 | 3,094.95 | 2,938.81 | |
| Expenses | |||||
| Material consumed | 2,194.78 | 1,851.29 | 1,537.18 | 1,275.27 | |
| Manufacturing expenses | 112.89 | 107.94 | 68.97 | 68.08 | |
| Personnel expenses | 613.93 | 548.50 | 425.30 | 395.15 | |
| Selling expenses | 107.33 | 138.71 | 122.94 | 85.53 | |
| Adminstrative expenses | 743.26 | 699.25 | 543.26 | 495.85 | |
| Expenses capitalised | - | - | - | - | |
| Cost of sales | 3,772.19 | 3,345.69 | 2,697.65 | 2,319.88 | |
| Operating profit | 617.92 | 97.53 | 397.30 | 618.93 | |
| Other recurring income | 202.06 | 341.07 | 223.59 | 197.97 | |
| Adjusted PBDIT | 819.98 | 438.60 | 620.89 | 816.90 | |
| Financial expenses | 107.10 | 115.87 | 53.55 | 4.71 | |
| Depreciation | 205.26 | 192.08 | 130.64 | 143.64 | |
| Other write offs | - | - | - | - | |
| Adjusted PBT | 507.62 | 130.65 | 436.70 | 668.55 | |
| Tax charges | 116.40 | 54.19 | 81.18 | 115.28 | |
| Adjusted PAT | 391.22 | 76.46 | 355.52 | 553.27 | |
| Non recurring items | -3.78 | -9.53 | -12.18 | 15.77 | |
| Other non cash adjustments | - | - | - | - | |
| Reported net profit | 387.44 | 66.93 | 343.34 | 569.04 | |
| Earnigs before appropriation | 1,359.23 | 985.19 | 912.38 | 569.04 | |
| Equity dividend | - | - | - | - | |
| Preference dividend | - | - | - | - | |
| Dividend tax | - | - | - | - | |
| Retained earnings | 1,359.23 | 985.19 | 912.38 | 569.04 | |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis